Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1046/j.1365-2141.2002.03537_3.x | DOI Listing |
JAAD Case Rep
September 2024
Department of Dermatology, Medical University of Graz, Graz, Austria.
Front Cell Dev Biol
August 2024
Laboratory of Molecular Hematology, National Medical Research Center for Hematology, Moscow, Russia.
Biomedicines
April 2024
Laboratory of Clinical Research and Advanced Diagnostics, Centro di Riferimento Oncologico della Basilicata (IRCCS-CROB), 85028 Rionero In Vulture, Italy.
J Hematol
April 2024
Department of Pathology, HCA East Florida, Fort Lauderdale, FL, USA.
Hepatosplenic T-cell lymphoma (HSTCL) is rare and clinically very aggressive T-cell lymphoma. The majority of cases harbor γδ T-cell receptors (TCRs); however, in some even rarer cases, tumor cells harbor αβ TCR. Recent studies suggest that αβ cases may have distinct morphological characteristics and demonstrate an even more aggressive course.
View Article and Find Full Text PDFRinsho Ketsueki
February 2024
Department of Hematology, Nephrology, Rheumatology, Akita University Graduate School of Medicine.
The patient was a 21-year-old man who had been diagnosed with Crohn's disease and received infliximab and azathioprine six years earlier. He was admitted with fever and fatigue. Peripheral blood examination showed LDH 2,473 U/l and thrombocytopenia, and contrast-enhanced computed tomography (CT) showed hepatosplenomegaly.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!